ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Brain-computer interface startup Science Corp. raised $400 million in a Series D round, bringing its valuation to $3.5 billion. The funding, led by Khosla Ventures, supports its PRIMA chip for treating age-related macular degeneration. CEO Max Hodak hopes the FDA will approve the device for U.S. patients early next year.
Tap to vote and see what everyone thinks.
Summary by ByteBrief